Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
Circulation. Cardiovascular Quality and Outcomes
|
December 10, 2015
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery?
Francesco Saia, Laura Maria Beatrice Belotti, Paolo Guastaroba, et al.
International Journal of Cardiology
|
October 30, 2012
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: a real-life multicenter experience
Paolo Buja, Gianpiero D'Amico, Michela Facchin, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
February 16, 2022
Complete versus culprit-only strategy in older MI patients with multivessel disease
Simone Biscaglia, Andrea Erriquez, Matteo Serenelli, et al.
JAMA Cardiology
|
December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials
Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Giornale Italiano Di Cardiologia (2006)
|
April 7, 2020
[Position paper of the Italian Society of Interventional Cardiology (SICI-GISE): Management of patent foramen ovale in patients with cerebral or systemic thromboembolism - 2020]
Giuseppe Tarantini, Gianpiero D'Amico, Claudio Baracchini, et al.
Journal of the American College of Cardiology
|
January 14, 2017
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Giornale Italiano Di Cardiologia (2006)
|
April 12, 2017
[Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)]
Marianna Adamo, Roberto Bonmassari, Guglielmo Bernardi, et al.
European Radiology
|
October 16, 2007
Influence of intra-coronary enhancement on diagnostic accuracy with 64-slice CT coronary angiography
Filippo Cademartiri, Erica Maffei, Anselmo Alessandro Palumbo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
January 22, 2017
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels
Francesco Giannini, Azeem Latib, Marco B Ancona, et al.
International Journal of Cardiology
|
December 20, 2018
Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial
Jeremie Abtan, Gregory Ducrocq, Ph Gabriel Steg, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
Circulation. Cardiovascular Quality and Outcomes
|
December 10, 2015
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery?
Francesco Saia, Laura Maria Beatrice Belotti, Paolo Guastaroba, et al.
International Journal of Cardiology
|
October 30, 2012
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: a real-life multicenter experience
Paolo Buja, Gianpiero D'Amico, Michela Facchin, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
February 16, 2022
Complete versus culprit-only strategy in older MI patients with multivessel disease
Simone Biscaglia, Andrea Erriquez, Matteo Serenelli, et al.
JAMA Cardiology
|
December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials
Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Giornale Italiano Di Cardiologia (2006)
|
April 7, 2020
[Position paper of the Italian Society of Interventional Cardiology (SICI-GISE): Management of patent foramen ovale in patients with cerebral or systemic thromboembolism - 2020]
Giuseppe Tarantini, Gianpiero D'Amico, Claudio Baracchini, et al.
Journal of the American College of Cardiology
|
January 14, 2017
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Giornale Italiano Di Cardiologia (2006)
|
April 12, 2017
[Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)]
Marianna Adamo, Roberto Bonmassari, Guglielmo Bernardi, et al.
European Radiology
|
October 16, 2007
Influence of intra-coronary enhancement on diagnostic accuracy with 64-slice CT coronary angiography
Filippo Cademartiri, Erica Maffei, Anselmo Alessandro Palumbo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
January 22, 2017
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels
Francesco Giannini, Azeem Latib, Marco B Ancona, et al.
International Journal of Cardiology
|
December 20, 2018
Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial
Jeremie Abtan, Gregory Ducrocq, Ph Gabriel Steg, et al.
Page
of 9